NIPEP-CARE (NIBEC)

N/A

Report date: 2025/01/26 16:38:07

Base Information

Drug NameNIPEP-CARE (NIBEC)
Drug Alias Nameimmune modulating peptide (NIBEC)NIPEP-IBD
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseInflammatory Bowel DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNano Intelligent Biomedical Engineering Corp Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNano Intelligent Biomedical Engineering Corp Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseInflammatory Bowel DiseasesArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A